Hyperbaric Oxygen Therapy: Clinical Trials

3 trials for Hyperbaric Oxygen Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Unknown 1

Follow Hyperbaric Oxygen Therapy: new trials by email Literature Review of Hyperbaric Oxygen Therapy trials Research Report on Hyperbaric Oxygen Therapy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma
hyperbaric oxygen therapy plus Camrelizumab - Combinational Immunotherapy, Hepatocellular Carcinoma Non-Resectable
Phase 1UnknownZhang Bi Xiang, MD202021-10-302023-12-19
Treatment of U.S. Veterans With Mild Traumatic Brain Injury With Hyperbaric Oxygen Therapy
Oxygen 100 % Gas for Inhalation, Hyperbaric Oxygen Therapy Chamber - Mild Traumatic Brain Injury, Hyperbaric Oxygen Therapy
Phase 1CompletedNova Southeastern University402021-09-072025-08-26
HBOT Application in Erectile Dysfunction
Hyperbaric oxygen therapy - Erectile Dysfunction, Hyperbaric Oxygen Therapy
Phase 1CompletedAssaf-Harofeh Medical Center372013-06-012015-12-03

Narrower conditions

Brain Concussion (1)  ·  Carcinoma, Hepatocellular (1)  ·  Depression (1)  ·  Erectile Dysfunction (1)  ·  Suicide (1)

Broader conditions

Adenocarcinoma (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Brain Injuries (1)  ·  Brain Injuries, Traumatic (1)  ·  Carcinoma (1)  ·  Central Nervous System Diseases (1)  ·  Craniocerebral Trauma (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Head Injuries, Closed (1)  ·  Liver Diseases (1)

Interventions

Hyperbaric Oxygenation (2)  ·  Gases (1)  ·  Inhalation (1)  ·  Oxygen (1)  ·  camrelizumab (1)

Sponsors

Assaf-Harofeh Medical Center (1)  ·  Nova Southeastern University (1)  ·  Zhang Bi Xiang, MD (1)

Countries

China (1)  ·  Israel (1)  ·  United States (1)

Top investigators

Alison C Bested, MD FRCPC (1)